Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Conditional survival to assess prognosis in patients with chronic lymphocytic leukemia.
Ann Hematol. 2024 May;103(5):1613-1622. doi: 10.1007/s00277-024-05627-w. Epub 2024 Feb 3.
Ann Hematol. 2024.
PMID: 38308707
Free PMC article.
Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study.
Weber MS, Buttmann M, Meuth SG, Dirks P, Muros-Le Rouzic E, Eggebrecht JC, Hieke-Schulz S, Leemhuis J, Ziemssen T.
Weber MS, et al. Among authors: hieke schulz s.
Front Neurol. 2022 May 9;13:863105. doi: 10.3389/fneur.2022.863105. eCollection 2022.
Front Neurol. 2022.
PMID: 35614917
Free PMC article.
Item in Clipboard
A multicentre analytical comparison study of inter-reader and inter-assay agreement of four programmed death-ligand 1 immunohistochemistry assays for scoring in triple-negative breast cancer.
Noske A, Ammann JU, Wagner DC, Denkert C, Lebeau A, Sinn P, Kreipe HH, Sommer U, Baretton G, Steiger K, Kiechle M, Hieke-Schulz S, Flores M, Roth W, Weichert W.
Noske A, et al. Among authors: hieke schulz s.
Histopathology. 2021 Mar;78(4):567-577. doi: 10.1111/his.14254. Epub 2020 Nov 27.
Histopathology. 2021.
PMID: 32936950
Item in Clipboard
Multicentric Analytical and Inter-observer Comparability of Four Clinically Developed Programmed Death-ligand 1 Immunohistochemistry Assays in Advanced Clear-cell Renal Cell Carcinoma.
Sommer U, Eckstein M, Ammann J, Braunschweig T, Macher-Göppinger S, Schwamborn K, Hieke-Schulz S, Harlow G, Flores M, Wullich B, Wirth M, Roth W, Knüchel R, Weichert W, Baretton G, Hartmann A.
Sommer U, et al. Among authors: hieke schulz s.
Clin Genitourin Cancer. 2020 Oct;18(5):e629-e642. doi: 10.1016/j.clgc.2020.02.009. Epub 2020 Feb 15.
Clin Genitourin Cancer. 2020.
PMID: 32178978
Free article.
Item in Clipboard
Design of a non-interventional post-marketing study to assess the long-term safety and effectiveness of ocrelizumab in German real world multiple sclerosis cohorts - the CONFIDENCE study protocol.
Dirks P, Zingler V, Leemhuis J, Berthold H, Hieke-Schulz S, Wormser D, Ziemssen T.
Dirks P, et al. Among authors: hieke schulz s.
BMC Neurol. 2020 Mar 14;20(1):95. doi: 10.1186/s12883-020-01667-7.
BMC Neurol. 2020.
PMID: 32171264
Free PMC article.
Item in Clipboard
Reasons to switch: a noninterventional study evaluating immunotherapy switches in a large German multicentre cohort of patients with relapsing-remitting multiple sclerosis.
Mäurer M, Tiel-Wilck K, Oehm E, Richter N, Springer M, Oschmann P, Manzel A, Hieke-Schulz S, Zingler V, Kandenwein JA, Ziemssen T, Linker RA.
Mäurer M, et al. Among authors: hieke schulz s.
Ther Adv Neurol Disord. 2019 Dec 19;12:1756286419892077. doi: 10.1177/1756286419892077. eCollection 2019.
Ther Adv Neurol Disord. 2019.
PMID: 31903096
Free PMC article.
Item in Clipboard
Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays.
Schwamborn K, Ammann JU, Knüchel R, Hartmann A, Baretton G, Lasitschka F, Schirmacher P, Braunschweig T, Tauber R, Erlmeier F, Hieke-Schulz S, Weichert W.
Schwamborn K, et al. Among authors: hieke schulz s.
Virchows Arch. 2019 Nov;475(5):599-608. doi: 10.1007/s00428-019-02610-z. Epub 2019 Jul 2.
Virchows Arch. 2019.
PMID: 31267201
Free PMC article.
Item in Clipboard
Cite
Cite